Thyroid Hormone Replacement for Subclinical Hypothyroidism

Status Completed

Clinical Trial Summary

Subclinical hypothyroidism (SCH) is a common condition among older men and women. Although by definition SCH comprises biochemically mild thyroid hormone deficiency without overt symptoms, it is a possible contributor to multiple problems in older age. Thyroid hormone has effects on numerous physiological systems, including the vascular tree, heart, skeletal muscle and brain. Therefore, thyroxine substitution to overcome thyroid hormone deficiency has the potential to give multisystem benefits to older people with SCH.

Small studies have reported reduced atherosclerosis and improved heart function with thyroxine replacement, but no large clinical trials have been performed. Therefore the available evidence is limited, leading to major variations in guidelines and clinical practice, with uncertainty regarding the indications for screening and treatment. The investigators propose a multicentre randomised placebo controlled trial to assess the impact of thyroxine replacement in a minimum of 540 older adults (maximum 750) with persisting SCH (excluding those in whom it is a temporary phenomenon who are unlikely to benefit). The investigators will include older men and women with a wide age range and of varying health status. Outcomes include health related quality of life, muscle strength, executive cognitive function and cardiovascular events, with a minimum of 1 year of follow up. Blood and urine samples will be stored in a biobank, to allow future research on causes of ill health in older people with SCH.

The investigators have the support of patient advocacy groups and a consortium with the wide range of expertise and experience required to conduct large scale multicentre clinical trials. The proposal explores the multisystem and quality of life benefits to older people of a tailored approach to management of SCH.

This clinical trial should definitively clarify whether thyroxine treatment for SCH provides benefits that are relevant for patients. This trial will provide strong evidence with the potential to improve clinical practice, reduce health care costs and promote healthy ageing of older adults.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01660126
Study type	Interventional
Source	NHS Greater Glasgow and Clyde
Contact
Status	Completed
Phase	Phase 4
Start date	May 2014
Completion date	November 18, 2016

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05019118` - Dietary Intervention With Únicla Dairy Products (DANTIAN)	N/A
Completed	`NCT01838031` - Thyroid Screening Protocol During Pregnancy: a Multi-center Prospective Controlled Study	N/A
Completed	`NCT01335802` - Relation Between Subclinical Hypothyroidism and Outcome of Pregnancy
Terminated	`NCT00962221` - Lipids Profile in Subclinical Hypothyroidism	N/A
Completed	`NCT00388297` - Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy	Phase 3
Completed	`NCT03898622` - Supplementation of Thyroid Hormone for TSH Control in Patients With Chronic Kidney Disease Without TRR.	Phase 3
Completed	`NCT01985204` - Iodine Supplementation in Obesity	N/A
Recruiting	`NCT06041204` - Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism	N/A
Completed	`NCT04354896` - The Effect of Thyroid Hormone Therapy on Muscle Mass and Function in Older Adults With Subclinical Hypothyroidism	Phase 4
Completed	`NCT02090907` - Effects of Levothyroxine on Endothelial Function of Patients With Subclinical Hypothyroidism	Phase 2/Phase 3
Completed	`NCT04288115` - Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism	Phase 4
Completed	`NCT01853579` - The TRUST Study - Depression Substudy	Phase 4
Completed	`NCT00921050` - Subclinical Hypothyroidism and Mind in the Elderly	Phase 2/Phase 3
Completed	`NCT00535561` - Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism	Phase 1
Completed	`NCT00498238` - The Effect of Levothyroxine on Arterial Stiffness and Lipid Profile in Patients With Subclinical Hypothyroidism	N/A
Completed	`NCT03036956` - The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan	N/A
Completed	`NCT02061111` - NeoThyr - the Role of Mitochondria-dysfunction in Newborns of Mothers With Autoimmune Thyroid Disease
Completed	`NCT01832753` - Treatment Trial of Subclinical Hypothyroidism in Down Syndrome	N/A
Completed	`NCT02399475` - Mechanistic Study of Subclinical Hypothyroidism In the Elderly	N/A
Completed	`NCT00437931` - Color Flow Doppler Ultrasound in Subclinical Thyroid Dysfunction	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Thyroid Hormone Replacement for Subclinical Hypothyroidism — TRUST

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms